CA9 and renal cell carcinoma: Considering other markers commonly evaluated when dealing with renal cell carcinomas, CA9 was expressed by 6 of 35 (17%), 2 of 35 (6%), and none of 35 (0%) MiT family translocation renal cell carcinomas, respectively, using a 5%, 10%, and 20% cutoff.